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Abstract
A fundamental challenge in the post-genome era is to understand and annotate the consequences of genetic variation,
particularly within the context of human tissues. We present a set of integrated experiments that investigate the effects of
common genetic variability on DNA methylation and mRNA expression in four human brain regions each from 150
individuals (600 samples total). We find an abundance of genetic cis regulation of mRNA expression and show for the first
time abundant quantitative trait loci for DNA CpG methylation across the genome. We show peak enrichment for cis
expression QTLs to be approximately 68,000 bp away from individual transcription start sites; however, the peak
enrichment for cis CpG methylation QTLs is located much closer, only 45 bp from the CpG site in question. We observe that
the largest magnitude quantitative trait loci occur across distinct brain tissues. Our analyses reveal that CpG methylation
quantitative trait loci are more likely to occur for CpG sites outside of islands. Lastly, we show that while we can observe
individual QTLs that appear to affect both the level of a transcript and a physically close CpG methylation site, these are
quite rare. We believe these data, which we have made publicly available, will provide a critical step toward understanding
the biological effects of genetic variation.
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Introduction
With the widespread application of highly parallel SNP
genotyping arrays much of the recent effort in human genetics
has focused on defining the role of genetic variation in disease and
physical traits. A small subset of this work, however, has attempted
to examine the more proximal effects of genetic variation on
mRNA and protein levels [1–5]. This has the potential to inform
on several levels; first, it is a critical step toward understanding the
pathobiological consequences of genetic variants linked to disease;
second, it affords the opportunity to form inferences regarding
relationships between genes based on patterns of co-regulation;
and third, it provides a more complete view of multiple levels of
regulation of gene expression than that provided by the traditional
reductionist method [6,7].
Epigenetic alterations, including DNA methylation, histone
modification and RNA mediated gene silencing, are defined as
heritable changes in gene function that occur without an alteration
of the underlying DNA sequence and which afford a level of
transcriptional regulation above and beyond DNA sequence [8].
DNA methylation, which occurs at discrete CpG dinucleotide
motifs, is believed to be an important mediator of gene expression;
this observation has been most frequently linked to DNA
methylation at CpG islands, regions of the genome that contain
a high density of CpG sites, often proximal to gene promoter
regions. A classical inverse relationship between the extent of DNA
methylation at CpG islands and expression levels of the proximal
gene product has been most often described [8]. To date the
relationship between genetics, DNA methylation and gene
expression is one that has been largely and necessarily confined
to observations at single loci and transcripts in individual cell
systems or tissues. The recent development of genome-scale
technologies provides unprecedented opportunities to expand
upon these experiments. The integration of genetic, epigenetic and
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ing the relationship between genetic variation and expression.
Beyond these observations these data can be readily mined to
unravel the network of effects associated with genomic variants.
This may reveal some of the rather cryptic intermediate events
that occur between DNA variant and phenotype.
Because of our interest in genomic regulation of expression and
neurological disorders we embarked upon a series of experiments
to provide a brain region-specific contextual framework for genetic
and epigenetic regulation of gene expression. We were particularly
interested in mapping the effects of common genetic variation on
gene expression and DNA methylation; the widespread adoption
of genome wide association studies for disease and traits has
generated a large number of associated loci, and such a map would
allow these loci to be associated with a biological consequence. We
obtained frozen brain tissue from the cerebellum (CRBLM),
frontal cortex (FCTX), pons (PONS) and temporal cortex (TCTX)
from 150 subjects (total 600 tissue samples). We undertook three
separate assays across this series; first, genome-wide SNP
genotyping; second, assay of 27,578 CpG methylation sites in
each of the four brain regions; third, mRNA expression profiling
of 22,184 transcripts in all four brain regions. Here we discuss the
results of these experiments, particularly in the context of
integrated datasets to define expression quantitative trait loci
(eQTL) and CpG methylation quantitative trait loci (methQTL),
where quantitative trait loci (QTL) are correlations between
genetic variation within genomic region(s) (in this case single
nucleotide polymorphisms) and a quantitative trait (DNA
methylation or expression), and detailing differences and similar-
ities across brain regions.
Results
CpG methylation and mRNA levels differ between brain
regions
To assess whether differences in CpG methylation and
expression were consistently different between brain regions, our
initial analyses focused on global comparison of these measures
across tissues. Performing a hierarchical cluster analysis [9] of
these data demonstrated that the four brain regions have different
epigenetic and expression profiles (Figure 1A and 1B). Expression
pattern differences were distinct between cerebellum, pons and
cortical tissue, with frontal and temporal cortices clearly separating
within the mRNA dataset, but overlapping within the CpG
methylation data. These data show that CpG methylation and
mRNA levels vary measurably between brain regions. These data
are in agreement with previous work that demonstrated distinct
patterns of gene expression and DNA methylation in human
cerebellum compared to cortical tissues [10,11].
The next analysis was limited to the CpG methylation and
mRNA datasets of those probes where an Illumina detection p-
value of less than or equal to 0.01 was observed in 95% of samples
analyzed in each of the four tissue region. This provided data on a
total of 27,277 unique CpG methylation sites and 8,076 probes
against individual mRNA transcripts that were present in all four
brain regions (Figure S2). The distribution of observed CpG
methylation levels and transcript abundance was plotted as a
histogram for each tissue (Figure 1C and 1D). A high proportion of
CpG sites interrogated within this assay were infrequently
methylated, whereas a smaller proportion were highly methylated,
a trend that was apparent across tissues. This distribution of DNA
methylation (Figure 1C) closely matches distributions of DNA
methylation reported previously by sequencing in multiple human
cell types [12,13]. CpG sites that are within CpG Islands [14,15]
were predominately unmethylated. Grouping of mRNAs into high
through low expression groups revealed abundance profiles similar
to those previously reported (Figure 1D). We next compared CpG
methylation and mRNA expression levels at individual loci directly
between each possible pair of tissue regions (Figure 1C and 1D,
scatterplots). In general levels of DNA methylation and expression
were quite similar between tissues. Measures within frontal and
temporal cortices were consistently the most alike and cerebellar
tissue provided the most distinct profile of the four regions.
Genotype influences CpG methylation and mRNA
expression
A primary aim underlying these experiments was to examine
the extent of genetic control of DNA methylation and expression
within brain tissues. To investigate this process, we undertook a
series of QTL analyses. From the 537,411 genotyped SNPs that
passed quality control filtering we then imputed genotypes for
2,545,178 SNPs using MACH [16] and HapMap CEU phase
data. After additional quality and analysis specifications filtering of
the imputed genotypes 1,629,853 SNPs (average) were used for
analysis. The QTL analysis of each tissue region was performed
separately so we expanded our trait selection from those that were
detected in 95% of samples across all four brain regions to those
that were detected in 95% of samples within a specific brain
region. Changing this trait selection threshold based on what is
present within a specific brain region allowed us to analyze
additional mRNA transcripts that are well detected within one or
more brain regions but not all four tissue regions. The number of
SNPs, CpG sites and mRNA transcripts tested for each brain
tissue can be found in Table 1. With these data for each tissue we
then performed linear regression of allele dosage against each
measure using CpG methylation or expression of mRNA as the
dependent variable and genotype as the independent variable.
This regression analysis was performed with Plink [17] to correlate
allele dosage with the quantitative trait. We corrected for number
of tests per trait by permutation, computing a genome-wide
empirical p-value for each of the ,1.6 million SNPs tested against
each individual trait. To correct for the number of traits tested
within each brain region by assay type an FDR threshold for
significance was determined based on the empirical p-values from
the proceeding step. This yielded a necessarily conservative
threshold for significance [18]. Prior to analysis each trait was
adjusted using available biological and methodological covariates
in an attempt to reduce the influence of systematic confounding
effects (Text S1). Post hoc we annotated significant QTLs as cis if the
SNP lay within 1MB of either the CpG methylation site in
question or the transcript being tested; all other SNP-dependent
Author Summary
In this paper, we describe a comprehensive assessment of
the correlation between common genetic variability across
the human genome, gene expression, and DNA methyla-
tion, within human brain. We studied the cerebellum,
frontal cortex, temporal cortex, and pons regions of 150
individuals (600 tissue samples). In each tissue, we
assessed 27,578 DNA methylation sites and the expression
level of 22,184 genes. Our research shows that DNA
methylation and RNA expression patterns differ between
brain regions. Further, we show that DNA genotype is
correlated with gene expression and DNA methylation,
particularly when the genetic variation is close to the DNA
methylation site or gene.
Brain QTLs for DNA Methylation and Expression
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tion of cis and trans QTL tests was performed post hoc, there was no
distinction in terms of level of statistical correction between these
groups.
Our previous data from the human cerebral cortex [2], as well
as data from HapMap lymphoblastoid cell lines (LCL) [5] have
suggested that SNPs proximal to genes including SNPs upstream
of the transcriptional start site (TSS) within the gene and
Figure 1. Analysis of CpG methylation and mRNA measures across four human brain regions. (A,B), unsupervised cluster analysis of CpG
methylation levels at autosomal loci and mRNA expression levels. Data arising from each brain region are colored accordingly and demonstrate
consistent separation of cerebellum, pons and cortical samples, with separation of frontal and temporal cortex samples using mRNA transcript levels.
(C,D) Tissue based pairwise comparisons of CpG methylation and mRNA expression. The analyses in these figures used cleaned data. Histograms
show the distribution of CpG methylation levels and mRNA expression levels for each tissue. Scatter plots are direct comparison of the level of each
detected transcript or methylation level in each tissue pair. Notably frontal cortex and temporal cortex show the most similar patterns of CpG
methylation and expression; conversely, all comparisons against cerebellar tissue show this tissue to have the most distinct patterns for all measures.
doi:10.1371/journal.pgen.1000952.g001
Brain QTLs for DNA Methylation and Expression
PLoS Genetics | www.plosgenetics.org 3 May 2010 | Volume 6 | Issue 5 | e1000952downstream of the transcript end site (TES) have a greater
influence on gene expression than those further away. This is
presumably because genetic variation around promoter elements,
splice sites and 39 UTR affects transcription, splicing and mRNA
stability [19] that results in a relative enrichment of cis over trans
eQTLs. To see if this observation generalized to multiple brain
regions and also to QTLs linked to CpG methylation, we plotted
all significant QTLs by genomic position of the SNP and transcript
or SNP and CpG site (Figure 2).
Previous work has shown that SNPs are weakly correlated with
the methylation status of CpG islands as compared to other DNA
characteristics such as sequence and structure [15]; however we
detected a large number of significant correlations detected
between genetic variation and the methylation status of CpG sites
(Table 2). Genome-wide visualization of detected methQTLs
illustrated a strong positional effect of this relationship with an
excess of the number and magnitude of cis associations
(Figure 2A). The detected methQTLs accounted for between
18% and 88% of corrected methylation levels at individual loci.
The number of CpG sites with methQTLs that were significant
after correction for genome-wide multiple testing ranged from
1085 (4%) in the cerebellum to 1417 (5.1%) in the temporal
cortex (Table 2). All significant methQTL results can be found in
Table S3. Detection of cis QTL for DNA methylation was more
likely when the CpG site was outside of an island (as defined
in [14]); while 42% of sites on the array are within a CpG island,
only 18% of the CpG sites with a significant QTL were in
islands.
A similar number of mRNA transcripts with significant eQTLs
were detected in each of the four brain regions, ranging from 280
(3.2%) in the pons to 391 (4.2%) in the temporal cortex (Table 3).
These eQTLs accounted for between 18% and 77% of corrected
expression levels of associated transcripts between individuals. All
significant eQTL results can be found in Table S4.
Proportionally a similar number of QTLs were observed for
CpG methylation and mRNA expression. In order to determine
whether SNP variability was more influential in CpG methylation
or expression, we performed a random sampling, with 10,000
iterations, of QTL calculations for each independent measure in a
core set of 100 individuals (Text S1). The results of this analysis
show on average that 2.34% of CpG sites and 1.99% of mRNAs
significantly correlate with QTLs. Each mRNA correlated with
twice as many SNPs, on average, than CpG sites did. However the
average R
2 of the SNPs correlated with mRNAs was equal to
CpGs (Figure S6).
The abundance of cis QTL for CpG methylation and mRNA
expression prompted us to examine the distribution of cis
methQTLs and eQTLs (Figure 2C–2L). This revealed that both
the number of significant methQTLs and the strength of
association between SNP and DNA methylation level were
inversely correlated with physical distance between the genetic
and epigenetic variants in question (Figure 2C–2F). Furthermore,
this relationship was also evident for cis eQTLs (Figure 2H–2K).
The average distance between correlated cis SNP and trait was
81Kb for CpG sites and 121Kb for mRNA transcripts. The largest
effect QTLs for both cis methQTLs and eQTLs tended to be
present in all four tissues tested (Figure 2G and 2L). Of the mRNA
transcripts where a cis eQTL was significantly detected in at least
one brain region 53% have been previously reported. This
number increased to 70% when analysis is limited to those
transcripts with a cis eQTL consistently detected in all four tissues
[2–4] (Table S2).
To assess the enrichment of detected cis QTLs relative to those
in trans we calculated the number of observed and possible cis and
trans QTLs for CpG methylation and mRNA expression levels.
The calculation of possible cis QTLs was performed by counting
the number of all testable, genotyped SNPs within 1Mb of the
CpG probe or transcript in question, regardless of significant
association; calculation of possible trans QTLs was performed by
counting the number of all testable, genotyped SNPs throughout
the genome, excluding those within 1Mb of the CpG probe or
transcript in question, again, regardless of significant association.
This analysis was repeated for every tested CpG probe and
transcript. These data showed an extreme enrichment of cis
methylation and expression QTLs relative to trans (,4400-fold
and ,7300-fold respectively). Although it should be noted that this
calculation of enrichment does not take into account the
differences in power to detect cis versus trans affects, thus the
extreme nature of these fold changes may be inflated. While the
average distance between correlated cis SNP and trait was 81Kb
for CpG sites and 121Kb for mRNA transcripts when cis is defined
as 1Mb, the peak enrichment of the number of significant cis
QTLs was observed when the threshold distance for what is
considered cis was set at ,45bp for CpG sites and ,68kb for
mRNA transcripts (Figure 3).
Large effect QTLs are consistent across brain regions
Based on our results that reached statistical significance many
QTLs appear to be tissue specific, where 49% of CpG sites and
54% of mRNA transcripts with a significant cis QTL were only
detected within one tissue. Table 4 shows summary counts of CpG
sites and mRNA transcripts with a QTL found in all four tissues.
Because this analysis relies on a threshold for significance, it has
the potential to be misleading, discounting QTLs that do not quite
reach the threshold for significance. Thus, in order to compare
detected methQTLs and eQTLs between tissues, we selected every
SNP-CpG methylation pair and SNP-transcript pair that passed
the defined threshold for significance in at least one tissue. We
then compared R
2 values for each of these SNP-CpG pairs or
SNP-transcript pairs in all four tissues, including results from
Table 1. Summary counts of number of samples, traits, and SNPs tested per tissue and assay type.
Counts of Tested Items
CpG mRNA
CRBLM FCTX PONS TCTX CRBLM FCTX PONS TCTX
Samples 108 133 125 127 143 143 142 144
Probes 27310 27532 27476 27538 8984 9842 8722 9372
SNPs 1540472 1624830 1602245 1607740 1653451 1653458 1650475 1655958
doi:10.1371/journal.pgen.1000952.t001
Brain QTLs for DNA Methylation and Expression
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significant, using ternary plots (Figure 4). The majority of large
effect and many moderate effect QTLs were shared across the four
brain regions (Figure 4) when significant effects from a tissue are
compared with corresponding (possible non-significant) effects
from another tissue. Of interest, a subset of trans methQTLs
(defined here as any SNP CpG pair not within 1MB of each other)
was also shared between regions and had high R
2 values. This
suggests that, while methQTLs show cis enrichment, there are also
a number of robust distal effects where SNP and CpG methylation
show significant association.
These plots illustrate that the majority of eQTLs or methQTLs
with strong effect sizes were consistent across tissues. For example,
a large effect eQTL was found for CHURC1, which encodes a
protein proposed to be involved in transcriptional regulation, in all
tissues (Figure S7 and as reported previously [3]). However, there
were also rare, but observable, events where a large effect QTL
was detected within a single tissue and was completely absent in
the other three tissues. For example the cis eQTL for PPAPDC1A,
encoding a phosphatidic acid phosphatase that displays hydrolase
and phosphotase activity at the membrane, has a large effect that
appears to be restricted to the cerebellum, despite reliable
Figure 2. Quantitative trait loci (QTL) for CpG methylation (methQTL), mRNA expression (eQTL) in four brain regions. (A,B), methQTL
and eQTL respectively, where the Y-axis represents the physical location of the QTL SNP and the X-axis the physical location of the QTL probe (CpG
site or mRNA). The size of each point reflects the relative strength of the association (R
2). (A) The excess of points along the diagonal illustrates that
detected methQTL are predominantly cis acting; but that trans methQTLs with high R
2 values exist across multiple tissues. (B) Shows the majority of
eQTL loci are in cis and that the in cis effect sizes are larger that those observed in trans. (C–G) cis methQTL results showing a symmetric association
between methylation level and variants on both sides of the CpG site in all four brain regions. (H–L) cis eQTL results showing a symmetric association
between expression level and variants on both sides of the transcription start site (TSS, corrected for strand) in all four brain regions. G and L show
the average p value for significant methQTL or eQTL across regions. For both methQTL and eQTL the more significant cis QTLs tended to be both
closer to the transcriptions start site or CpG methylation site and common across tissue regions tested.
doi:10.1371/journal.pgen.1000952.g002
Brain QTLs for DNA Methylation and Expression
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4R–4T and Figure S8).
methQTL and eQTL capture independent traits
We next sought to investigate whether the observed methQTLs
and eQTLs represent individual loci where the underlying variant
influences both CpG methylation and gene expression. These data
revealed that in general, there was little co-association between
methQTLs and eQTLs. Of the SNP, CpG and mRNA
combinations considered (see Materials and Methods), 4.8%
(average across tissues) were significant as both a methQTL and
eQTL; this includes 2.6% (average of 13 sites per tissue) of CpG
methylation sites where a significant methQTL is present and
8.2% (average of 11 transcripts per tissue) of mRNA transcripts
that have a significant eQTL.
For this 4.8% with a shared QTL both the mean distance
between the CpG site and mRNA TSS and the strength of the
correlation differed from that of the considered combinations. For
the shared QTLs the distance between CpG site and mRNA TSS
is 27.5Kb whereas in all considered the mean distance was
394.4Kb. The mean R
2 between CpG methylation and mRNA
expression within the shared QTL set was 0.255 as compared to
0.033 in the considered set. Within these possibly shared QTLs,
almost half of the significant methQTLs and eQTLs were
correlated in the same direction, i.e. the CpG methylation level
was positively correlated with the mRNA expression level (Figure
S9). However; when considering only those shared QTLs where
the CpG site was within a CpG island (as defined in [14]), 91% of
these CpG methylation sites and mRNA expression pairs are
inversely correlated, in line with the traditional view that increased
CpG island methylation is associated with decreased expression at
geographically local transcripts (Figure 5).
Discussion
Elucidating the genetic control of biological processes is a
critical issue in the post genome era. This will inform on the basic
biological level and lead to clearer understanding of the
pathophysiology underlying human disease. The work we have
described here and the public release of the data resulting from
this effort, aims to facilitate an understanding of the
initial consequences of common genetic variation on DNA
methylation and gene expression in brain (GEO Accession
Number: GSE15745; dbGAP Study Accession: phs000249.v1.p1)
[20–22].
Our data show clearly that patterns of expression are
measurably different across brain tissues. QTL analyses reveal
an abundance of eQTLs and, as previously reported, significant
eQTLs are predominantly cis in nature [2,5]. It is notable,
particularly given the systematic differences in expression patterns
among the four tissues, that the majority of large effect eQTLs
detected were consistent across brain tissues. Large effect tissue-
specific QTLs are also observable in the current data set,
suggesting that there are some genetic effects on expression that
are dependent on the tissue type used irrespective of expression
levels of the mRNA. Our results that reached statistical
significance are consistent with recent work showing that many
eQTLs are likely tissue specific, but they typically have a smaller
effect and are more distant [23–25]. However within our data
when we observe a QTL that is only significant in a single tissue,
examination of the correlation between the same SNP and trait in
other tissues generally reveals a suggestive, although non-
significant, correlation in the other tissues; thus both large and
many moderate size effects appear to be shared. While this aspect
of our data may seem at odds with the previous studies which in
part used purified cells or cell lines, the current samples within our
study were exclusively from heterogeneous tissues. Thus one might
expect to see quantitative trait loci that are generalizeable across
tissues because in essence each tissue is a heterogeneous mix of
cells and we are more likely to detect QTLs that are in a majority
of cell types. The detection of cell type specific QTLs is apparently
still feasible, however, such correlations will have to be large
enough to detect within the background of a heterogeneous tissue.
Table 2. Summary counts of significant methQTL results found per brain tissue.
Significant QTL Counts for CpG sites
CRBLM FCTX PONS TCTX
methQTL Pairs CpGs SNPs Pairs CpGs SNPs Pairs CpGs SNPs Pairs CpGs SNPs
cis 9117 444 8458 9242 420 8402 7966 359 7103 12081 547 10875
trans 2985 657 2158 2893 740 2287 3408 774 2459 4653 886 2895
total 12102 1085 10606 12135 1153 10679 11374 1123 9536 16734 1417 13761
doi:10.1371/journal.pgen.1000952.t002
Table 3. Summary counts of significant eQTL results (mRNA) found per brain tissue.
Significant QTL Counts for mRNA transcripts
CRBLM FCTX PONS TCTX
eQTL Pairs mRNAs SNPs Pairs mRNAs SNPs Pairs mRNAs SNPs Pairs mRNAs SNPs
cis 4053 147 4033 4781 167 4598 2944 102 2918 3509 141 3445
trans 1191 181 1079 734 170 612 471 179 369 1826 255 614
total 5244 319 4399 5515 334 5199 3415 280 3287 5335 391 4059
doi:10.1371/journal.pgen.1000952.t003
Brain QTLs for DNA Methylation and Expression
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methQTLs in human tissue. It is worth noting, however, that the
CpG methylation sites assayed here have not been defined
through experimental work; as such a proportion of these may be
consistently non-methylated, and thus our estimate of the
proportion of CpG sites with an associated methQTL may be
an underestimate. As for mRNA expression, DNA methylation
patterns are sufficiently different to predict the originating tissue;
however, we also see that SNP variation strongly influences the
level of DNA methylation at sites that show intermediate levels of
methylation. The strength of effect for methQTLs is similar to
those for eQTLs and as discussed above eQTLs and methQTLs
tend to be found consistently across tissues, supporting the
robustness of these loci. Additionally methQTLs also show cis-
enrichment, suggesting that local genomic variants influence the
propensity of a particular genomic site to be methylated.
Combined analysis of methQTLs and eQTLs did not reveal a
simple relationship between genetically influenced DNA methyl-
ation and expression. QTLs that influenced both DNA methyl-
ation and expression levels of a physically close transcript were
identified, these were in the minority; for the most part strong
methQTLs were not also QTLs for expression. It is plausible that
this observation reflects a genuine biological disconnect between
CpG methylation and gene expression. Alternatively, this may be
a result of poor power within the series to detect such effects or, as
discussed below, a consequence of differences in cellularity
confounding our results. Notably, when analyzing joint
methQTL-eQTLs where the methylation site in question resided
in a CpG island, the classical inverse relationship between CpG
methylation and expression was clearly observed.
Increasing the sample size of the current study will likely yield a
larger number of QTLs, particularly those with small to
moderate effect size. It would also be of interest to extend this
initial work to other tissues, which will not only be important in
defining tissue specific QTLs, but also will afford us the
opportunity to examine QTLs at transcripts not typically detected
in brain. Additionally, we have limited our sampling to a
population that represents only a small component of worldwide
human genetic diversity [26]. Adding tissues from other
populations would provide an understanding of genetic control
of expression in different groups and a framework for interpre-
tation of GWAS results in these groups. Furthermore, inter-
population comparison would help refine the basis by which
differences in genetic architecture affect expression. We also note
that our coverage of DNA modifications is currently incomplete
as there are other epigenetic modifications, such as acetylation,
that are not currently accessible to high throughput techniques,
and many more methylation sites exist than assayed here.
Whether genotypic differences influence other components of the
epigenome is unknown. Finally, in a complex organ such as brain
cellularity will confound analyses correlating measures that vary
Figure 3. Peak enrichment for QTLs. Plots showing the large cis enrichment of significantly identified QTLs over trans. For the paper and result
tables cis has been defined as SNPs and probes (CpG and mRNA) that are 61 Mb of each other. At this annotated definition of cis the enrichment of
results are on the right of these two plots x-axis, where the plots are all four brain tissue regions together. The left plot is for CpGs and the right for
mRNA. At 1 Mb the enrichment of cis to trans for CpG QTLs is 4,427-fold and for mRNA is 7,255-fold. These plots show how this enrichment changes
when considering other distances as a threshold for cis, the X-axis are these other distances (non-linear) at 50 distances that are four/fifths the size of
the next larger distance. The plots are based on the proportions of significant cis and trans SNP/Probe pairings from the possible pairings at different
distances.
doi:10.1371/journal.pgen.1000952.g003
Table 4. Summary counts of significant QTL results per assay
type identified that were present in all four tissues.
Significant QTL Counts Consistent across Tissues
CpG mRNA
QTLs Pairs Probes SNPs Pairs Probes SNPs
cis 2407 129 2336 1489 53 1489
trans 490 23 462 0 0 0
total 2897 152 2798 1489 53 1489
doi:10.1371/journal.pgen.1000952.t004
Brain QTLs for DNA Methylation and Expression
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tions pose a considerable challenge in heterogeneous tissues. In
the context of human tissues this problem may be solved by
selection of cell type by laser dissection or by culture and terminal
differentiation of cohorts of pluripotent stem cells. Both solutions
have considerable technical limitations at this time.
In summary, we show data that we argue convincingly
demonstrates QTLs for DNA methylation and expression exist
across human tissues. The data presented here provides an initial
basis for understanding how genetic variance in humans influences
epigenetic marks and expression; we argue that these observations
may be useful in the understanding of gene contributions to
Figure 4. Comparison of QTLs for CpG methylation and mRNA expression across tissue regions. Any QTL that passed our threshold for
significance in at least one tissue was included in the Ternary plots. The color of the points in the ternary plots reflects the cumulative R
2 value for all
tissues tested within each plot. Points toward the center indicate an equal R
2 value across the three regions under investigation. Points toward the
corner of a plot indicate a high R
2 in one of the three tissues; points toward the edges of the plot indicate a high R
2 in two of the three tissues. (A–H)
Comparing methQTL in every three-way combination of the the four tissues for cis (A–D) and trans (E–H). (I–P) eQTL comparisons across each group
of three tissues for cis and trans effects. Notably the cumulative R
2 is generally higher for cis compared to trans loci across both methQTL and eQTL.
Green circles highlight a cluster of relatively high cumulative R
2 values driven primarily by the observed R
2 within cerebellar tissue. These points were
revealed to be a cis eQTL involving 20 SNPs and two neighboring transcripts, PPAPDC1A and C10orf85. (Q–T) Boxplots show expression level plotted
against genotype for one of these eQTL SNP-transcript pairs (SNP rs2182513 and PPAPDC1A) and illustrate that this is a tissue specific QTL limited to
the cerebellum.
doi:10.1371/journal.pgen.1000952.g004
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PLoS Genetics | www.plosgenetics.org 8 May 2010 | Volume 6 | Issue 5 | e1000952Figure 5. Intersection of QTLs for CpG and mRNA traits. Plots shown for each tissue region; cerebellum, frontal cortex, pons and temporal
cortex. Per tissue for every pairing of CpG site and mRNA transcript where the CpG was within a CpG island and within 1Mb of the mRNA TSS and
both the CpG and mRNA have a significant cis QTL; i.e. a triplet is formed between SNP, mRNA and CpG, where the SNP was significantly correlated in
cis with either the CpG or mRNA of the CpG-mRNA cis pairs under consideration. For these triplets we plotted the eQTL R
2 (X axis) and the methQTL
R
2 (Y axis). The R
2 values are shifted into one of four quadrants (without changing the effect size) based on the positive and negative combinations of
correlations for the eQTLs and methQTLs. A positive correlation with mRNA means that the level of expression is increased with the minor allele of
the SNP and a negative correlation means that the mRNA expression level is decreased with the minor allele of the SNP. For CpGs a positive
correlation implies that the level of methylation is increased at a CpG site with the minor allele and a negative correlation implies that the level of
methylation is decreased with the minor allele. The top-left quadrant contains negative eQTL and positive methQTL correlations. The top-right
quadrant contains eQTLs and methQTLs where the correlation was positive in both. The bottom-left quadrant contains eQTLs and methQTLs where
the correlation was negative in both. The bottom-right quadrant contains positive eQTL and negative methQTL correlations. The triplets are plotted
as circles where the radius of the circle represent the R
2 value between the CpG site and mRNA transcript. The color of circle represents the distance
between the CpG site and the mRNA TSS, where red indicates that the CpG site is close and upstream to the mRNA TSS; blue indicates that the CpG
site is close to the mRNA TSS but downstream; and black indicates that the CpG site is farther from the mRNA TSS both up or downstream. Triplets
that fall along the main diagonals are those where a significant methQTL and eQTL are present; the CpG and mRNA pairs for these triplets are closer
together and have a larger R
2 between the CpG and mRNA. Triplets that are on or close to the X axis are those where there is a significant eQTL but a
lack of signal for the methQTL, likewise the items that are on or close to the Y axis are those with a significant methQTL and a lack of signal for the
eQTL.
doi:10.1371/journal.pgen.1000952.g005
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of the complex control of gene expression in the brain, our data
may be useful in moving rapidly from locus to mechanism of
disease.
Materials and Methods
Samples and assays
Frozen tissue samples of the cerebellum (CRBLM), frontal
cortex (FCTX), caudal pons (PONS) and temporal cortex (TCTX)
were obtained from 150 neurologically normal Caucasian subjects
(Text S1). 100–200mg aliquots of frozen tissue were sub-dissected
from each tissue from all 150 subjects resulting in 600 tissue
samples and used for methylation assay and expression assays.
Genotyping was performed using Infinium HumanHap550
beadchips (Illumina) to assay genotypes for 561466 SNPs, from
the cerebellum tissue samples. CpG methylation status was
determined using HumanMethylation27 BeadChips (Illumina),
which measure methylation at 27,578 CpG dinucleotides at
14,495 genes. Profiling of 22,184 mRNA transcripts was
performed using HumanRef-8 Expression BeadChips (Illumina)
as previously described [27].
Genotype data
The threshold call rate for inclusion of the subject in analysis
was 95%. All 150 subjects had a call rate greater than 95%, and
were included in the subsequent analyses (average call
rate=99.86%; range 97.72%–99.95%, based on the missing
procedure within the PLINK v1.04 software toolset [17].
The gender of the subjects reported by the brain banks was
compared against their genotypic gender using PLINK’s check-sex
algorithm, which determines a sample’s genotypic gender based on
heterozygosity across the X chromosome. A gender discrepancy
was detected for one subject and excluded from further analysis.
To confirm the ethnicity of the samples, Identity-By-State (IBS)
clustering and multidimensional scaling analyses were performed
within PLINK using the genotypes from the brain samples that
had been merged with data from the four HapMap [28]
populations (n=32 Caucasian (CEU), 12 Han Chinese, 16
Japanese and 24 Yoruban non-trio samples previously genotyped
by Illumina and assayed on the Infinium HumanHap500 version
genotyping chips). Two samples were outliers based on population
and excluded from further analysis (Figure S1).
Genotype data of the samples were compared for cryptic
relatedness using the Identity-By-Descent (IBD) procedure within
PLINK. No samples were found to be from related individuals.
Mach software version 1.0.16 [16] and HapMap CEU phase
data (release 22) were used to impute genotypes for ,2.5 million
SNPs. Imputed SNPs were excluded if the linkage disequilibrium
r
2 values between imputed and known genotypes was less than 0.3,
and if their posterior probability averages were less than 0.8 for the
most likely imputed genotype. For each of the four tissue regions,
SNPs were also excluded if: (a) call rate was less than 95%, (b)
Hardy-Weinberg equilibrium (HWE) p-value was less than 0.001,
and (c) the SNP had less than 3 minor homozygotes present. Exact
numbers of SNPs used per brain tissue and assay type are shown in
Table 1.
mRNA expression data
Raw intensity values for each probe were transformed using the
rank invariant normalization method [29–31] and then log2
transformed for mRNA analysis. Four samples were excluded
from further analysis, as they were outliers based on overall probe
detection rate and/or mean expression level; one CRBLM, one
FCTX and two PONS.
CpG methylation data
The threshold call rate for inclusion of samples in the analysis
was 95%. Based on this metric, 9 CRBLM, 2 FCTX, 6 PONS and
8 TCTX samples were excluded from further analysis. The
remaining brain samples had an average detection rate of 99.84%
(range 95.0% to 99.98%).
The gender of the samples reported by the brain banks were
compared against their assayed gender based on values of
methylation from CpG sites on the X chromosome. Four samples
with gender discrepancies were detected and were removed from
subsequent analysis; two CRBLM, one PONS and one TCTX.
The resulting HCL sample tree based on all Chromosome X
probes, after removal of these four individuals is shown in
Figure S3.
Clustering of samples by brain region
Performing a Hierarchical Clustering (HCL) [9] of the sample
profiles using the TM4 MeV version 4.1.01 tool [32], with
Euclidian distances and ‘Average Linkage clustering’ resulted in
the samples separating fairly well by brain tissue region. Where in
mRNA separation of samples into 4 clusters matching brain tissue
region was clear. The frontal and temporal cortices could not be
separated in within CpG data. For clustering all detected data was
used for mRNA; only detected data for autosomal probes was used
in clustering of the CpG data, otherwise sub-clusters based on
gender appeared. The HCL samples trees were saved a Newick
tree files and plotted again using the HyperTree tool (http://
hypertree.sourceforge.net/).
Selection of traits for analysis
Traits were excluded from analysis if they were detected in less
than 95% of samples for each tissue region. For each tissue region
and trait type (CpG and mRNA) the 95% threshold was
determined using total number of analyzable samples for this
pairing of region and trait. A probe is considered detected for a
sample if the reported Illumina Detection p-value was less than or
equal to 0.01. Numbers of analyzable samples per trait (or assay)
type and region are available in Table 1 overlap of detected probes
among brain tissues is shown as Venn diagram in Figure S2.
Correction for known biological and methodological
covariates
Prior to quantitative trait loci analysis each trait was adjusted
using the available biological and methodological covariates in an
attempt to remove the influence of these potentially confounding
affects. In R each trait was regressed using the following model:
Y~b0zb1X1z:::zbnXnze
Where Y is the trait profile (log2 normalized mRNA expression
intensities and raw values of CpG DNA methylation) and X1 …
Xn represent the biological covariates Age and Gender and the
methodological covariates post mortem interval (PMI), which
Brain Bank the samples was from and which preparation/
hybridization batch the sample was processed in. Within this
model gender, tissue bank and batch where treated as categorical
covariates. After fitting each trait to the model the residuals from
the model are kept and represent the trait in following analyses.
Thus variance attributable to gender, age, post-mortem interval,
tissue source and hybridization batch are removed prior to QTL
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Histograms showing the proportion of traits that are potentially
impacted by these covariates are shown in Figure S4 (CpG) and
Figure S5 (mRNA).
Quantitative trait loci analysis
For each of the four brain regions, a regression analysis was
performed on the residuals described in the preceding section for
(a) mRNA expression and (b) the methylation values generated for
CpG sites. The trait residuals were then used as the quantitative
phenotype for that probe in genome-wide association analysis
looking for quantitative trait loci. These analyses were performed
using the assoc function within Plink, which correlates allele dosage
with change in the trait. Each of the four tissue regions was
analyzed separately, and independent genome-wide association
analyses were performed looking for (a) expression quantitative
trait loci (eQTLs) for mRNA and (b) methylation quantitative trait
loci (methQTLs) for CpG sites. The Plink toolset quantitative trait
association analysis fits data to the following model:
Y~b0zb1ADDze
Where Y is the quantitative trait and ADD represent genotypes
encoded as allele dosage. See Plink Quantitative trait association
and Linear and Logistic models documentation for more
information.
Correction for multiple tests
To correct for the large number of SNPs tested per trait, a
genome-wide empirical p-value was computed for the asymptotic
p-value for each SNP by using 1,000 permutations of swapping
sample labels of the traits, using the maxT permutation
functionality provided within Plink. A permutation based method
using label swapping of the traits is an appropriate method of test
correction [18] for these analysis as it is not dependent on these
quantitative traits having a normal distribution and also allows the
linkage disequilibrium of the genomic regions being tested against
the traits to be maintained.
To correct for the number of traits being tested per tissue
region, a false discovery rate (FDR) threshold was determined
based on the empirical p-values using the fwer2fdr function of the
multtest package in R version 2.6.1. Empirical p-values were
allowed to exceed this threshold if their linkage disequilibrium r
2
was greater than or equal to 0.7 with a SNP with empirical values
within the FDR threshold.
Polymorphism(s) in assay probes
Sequence variants within the sequence of the probe used to
assay individual traits may cause differential hybridization and
inaccurate expression and possible methylation measurements. To
exclude this confound, the sequences of probes with significant
correlation to a trait were examined for the presence of
polymorphisms using CEU HapMap data, and, if present, that
QTL was removed from the result set.
Selecting SNPs, CpG sites, and mRNA transcripts for
shared QTL analysis
Within each tissue, we selected every pairing of CpG
methylation sites and mRNA transcripts where the CpG
methylation site was within 1Mb of the mRNA TSS and both
the CpG methylation site or mRNA transcript had a significant cis
QTL. These CpG-mRNA pairs were then expanded into triplets
of SNP and CpG-mRNA pair, where the SNP was significantly
correlated in cis with either the CpG methylation site or mRNA
transcript of the CpG-mRNA pair.
Accession numbers
Data resulting from these experiments is available online (GEO
Accession Number: GSE15745; dbGAP Study Accession:
phs000249.v1.p1).
Supporting Information
Figure S1 Population MDS plot based on genotype from
genome wide Identity-By-State pairwise distances between the
150 samples used in this study (LNG) and HapMap samples (CEU,
CHB, JPT and YRI). The plot shows that of the 150 samples
originating from reported Causasian individuals from the United
States, two samples (indicated by Removed labels) are ethnic
outliers relative to the LNG cohort.
Found at: doi:10.1371/journal.pgen.1000952.s001 (0.02 MB PDF)
Figure S2 Venn diagrams showing the frequency overlap of the
number of probes that are detected in 95% of samples between the
four brain tissues. Venn diagrams are shown for both CpG and
mRNA assay types. The rectangles with different orientations and
border, shown on the left legend represent the different tissue and
the different squares represent overlapping frequencies between
different tissues. The colored squares represent the number of
tissues overlapping, where the central blue square in each Venn
diagram represent the number of probes reliably detected in all
four tissues. Hence, the blue square in the mRNA diagram
indicates that 78.2% of the 10326 mRNA probes detected in at
least one tissue region were also detected in all four tissues regions
or 8076 probes.
Found at: doi:10.1371/journal.pgen.1000952.s002 (0.01 MB PDF)
Figure S3 This tree shows that male and female samples (using
all brain tissue regions) separate based on gender if a hierarchical
cluster is performed on CpG methylation data for only
Chromosome X CpG sites. The plot was generated in HypterTree
using the samples tree generated from an HCL of Chromosome X
methylation data using ‘Average Linkage clustering’. The plot is
after removal of the 4 individuals that appeared to be gender
mismatches.
Found at: doi:10.1371/journal.pgen.1000952.s003 (0.04 MB PDF)
Figure S4 Histograms of potential covariate effects on CpG
DNA methylation levels, if the data had not been adjusted for
these confounds prior to QTL analysis. Each row of sub-plots
represents a single covariate and each column represents a brain
tissue region; CRBLM (red), FCTX (green), PONS (blue) and
TCTX (purple). The histograms show the number of probes (CpG
sites) on the y-axis and the R
2 values from the regression of the
covariates with each probe.
Found at: doi:10.1371/journal.pgen.1000952.s004 (0.04 MB PDF)
Figure S5 Histograms of potential covariate effects on mRNA
expression levels, if the data had not been adjusted for these
confounds prior to QTL analysis. Each row of sub-plots represents
a single covariate and each column represents a brain tissue
region; CRBLM (red), FCTX (green), PONS (blue) and TCTX
(purple). The histograms show the number of probes (mRNA
transcripts) on the y-axis and the R
2 values from the regression of
the covariates with each probe.
Found at: doi:10.1371/journal.pgen.1000952.s005 (0.04 MB PDF)
Figure S6 Histograms representing the results of the resampling
analysis. Each row represents a different assay type (CpG and
mRNA) and each column represents a different metric of the
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and average R
2 of probe/SNP correlations.
Found at: doi:10.1371/journal.pgen.1000952.s006 (0.11 MB PDF)
Figure S7 These plots, one for each brain tissue, show the p-
values of correlations between SNPs and mRNA transcripts in a
500Kb region centered on CHURC1. Where a eQTL in this
genomic region is present in all four brain tissues. A cis QTL for
CHURC1 has also been reported within liver (Schadt et al., 2008).
Within each plot the X-axis is the physical position along this
region of the chromosome and the Y-axix is the 2log10(asymptotic
p-values) for the correlations. The p-values are colored and
numbered to match the annotated transcripts labeled in the top
portion of the plots. Thus in CRBLM, PONS and TCTX the dark
blue ‘5’s are p-values for CHURC1 and in FCTX the dark red ‘6’s
are p-values for CHURC1. mRNA transcript annotations shown
in grey are those where a probe in present on the expression
platform but are not detected in 95% of the tissue.
Found at: doi:10.1371/journal.pgen.1000952.s007 (0.43 MB PDF)
Figure S8 These plots show an example of a cis eQTL for an
mRNA that appears to be tissue specific. The plots, one for each
brain tissue, show the p-values of correlations between SNPs and
mRNA transcripts in a 1Mb region centered on PPAPDC1.
Within each plot the X-axis is the physical position along this
region of the chromosome and the Y-axix is the 2log10(asymptotic
p-values) for the correlations. The p-values are colored and
numbered to match the annotated transcripts labeled in the top
portion of the plots. Thus in CRBLM the red ‘2’s are p-values for
SNPs correlated with PPAPDC1A. Also present at this same
genomic locus is another tissue specific eQTL for the mRNA
transcript C10orf85, shown as green ‘3’s.
Found at: doi:10.1371/journal.pgen.1000952.s008 (0.51 MB PDF)
Figure S9 Intersection of QTLs for CpG and mRNA traits.
Plots shown for each tissue region; cerebellum, frontal cortex, pons
and temporal cortex. Per tissue for every pairing of CpG site and
mRNA transcript where the CpG was within 1Mb of the mRNA
TSS and both the CpG and mRNA have a significant cis QTL;
i.e., a triplet is formed between SNP, mRNA and CpG, where the
SNP was significantly correlated in cis with either the CpG or
mRNA of the CpG-mRNA cis pairs under consideration. For
these triplets we plotted the eQTL R2 (X axis) and the methQTL
R2 (Y axis). The R2 values are shifted into one of four quadrants
(without changing the effect size) based on the positive and
negative combinations of correlations for the eQTLs and
methQTLs. A positive correlation with mRNA means that the
level of expression is increased with the minor allele of the SNP
and a negative correlation means that the mRNA expression level
is decreased with the minor allele of the SNP. For CpGs a positive
correlation implies that the level of methylation is increased at a
CpG site with the minor allele and a negative correlation implies
that the level of methylation is decreased with the minor allele.
The top-left quadrant contains negative eQTL and positive
methQTL correlations. The top-right quadrant contains contains
eQTLs and methQTLs where the correlation was positive in both.
The bottom-left quadrant contains eQTLs and methQTLs where
the correlation was negative in both. The bottom-right quadrant
contains positive eQTL and negative methQTL correlations. The
triplets are plotted as circles where the radius of the circle
represent the R2 value between the CpG site and mRNA
transcript. The color of circle represents the distance between the
CpG site and the mRNA TSS, where red indicates that the CpG
site is closer upstream to the mRNA TSS; blue indicates that the
CpG site is close the the mRNA TSS but downstream; and black
indicates that the CpG site is farther from the mRNA TSS both up
or downstream. Triplets that fall along the main diagonals are
those where a significant methQTL and eQTL are present; the
CpG and mRNA pairs for these triplets are closer together and
have a larger R2 between the CpG and mRNA. Triplets that are
on or close to the X axis are those where there is a significant
eQTL but a lack of signal for the methQTL, likewise the items
that are on or close to the Y axis are those with a significant
methQTL and a lack of signal for the eQTL.
Found at: doi:10.1371/journal.pgen.1000952.s009 (1.74 MB PDF)
Table S1 Sample information, table containing the sample Id,
originating brain bank, age, gender, postmortem interval,
preparation/hybridization batch and cause of death where
available.
Found at: doi:10.1371/journal.pgen.1000952.s010 (0.04 MB
XLS)
Table S2 Table showing which mRNA transcripts indentified as
having an eQTL within the current study have also been identified
in another genome wide eQTL study.
Found at: doi:10.1371/journal.pgen.1000952.s011 (0.13 MB
XLS)
Table S3 Significant QTL results from the analysis of CpG sites
and SNPs for each brain tissue (CRBLM, FCTX, PONS, TCTX).
Table includes which tissue analysis the result is from (Tissue); the
Illumina ID for the CpG site (IlmnID); the chromosome and
position of the CpG site (Chr, Start_Pos and Stop_Pos); the gene
that has a transcription start site downstream and proximal the
GpG site (Symbol, GeneID and Strand); the SNP correlated with
the CpG site and its position (SNP, SNP_Chr and SNP_Position);
the gene closest to the SNP that is correlated with the CpG site
(Dist_SNP_Closest_Gene, SNP_Gene and SNP_GeneID); the
Hardy-Weinberg Equilibrium p-value (HWE) for the SNP based
on the samples used in the analysis for the specified tissue (Tissue);
the minor allele frequency (MAF) for the SNP based on the
samples used in the analysis for the specified tissue (Tissue); the call
rate for the SNP (SNP_Call_Rate) based on the samples used in
the analysis for the specified tissue (Tissue); the fraction of samples
used in the correlation between the SNP and CpG site based on
the number of samples used in the analysis for the specified tissue
(Tissue) where samples with missing genotypes or missing trait
value are not included in the analysis; annotations for the SNP and
CpG site are cis or trans where cis is +/2 1Mb (Dist_to_Trait and
cis_trans); the asymptotic p-value, empirical p-value, regression r-
squared and regression beta for the correlation (pvalue, empP, r2
and beta) note the empirical p-values equal to 0.000999 in the
table represent p-values less than 0.001 (based on 1K permuta-
tions); and the number of AA, AB and BB genotypes used in the
correlation (Num_AA, Num_AB and Num_BB).
Found at: doi:10.1371/journal.pgen.1000952.s012 (8.42 MB
TXT)
Table S4 Significant QTL results from the analysis of mRNA
transcripts and SNPs for each brain tissue (CRBLM, FCTX,
PONS, TCTX). Table includes which tissue analysis the result is
from (Tissue); the Illumina ID for the mRNA transcript (IlmnID);
position and annotations for the mRNA transcript (Symbol,
GeneID, Description, Chr, Start_Pos, Stop_Pos and Strand); the
SNP correlated with the mRNA transcript and its position (SNP,
SNP_Chr and SNP_Position); the gene closest to the SNP that is
correlated with the mRNA transcript (Dist_SNP_Closest_Gene,
SNP_Gene and SNP_GeneID); the Hardy-Weinberg Equilibrium
p-value (HWE) for the SNP based on the samples used in the
analysis for the specified tissue (Tissue); the minor allele frequency
(MAF) for the SNP based on the samples used in the analysis for
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Rate) based on the samples used in the analysis for the specified
tissue (Tissue); the fraction of samples used in the correlation
between the SNP and mRNA transcript based on the number of
samples used in the analysis for the specified tissue (Tissue) where
samples with missing genotypes or missing trait value are not
included in the analysis; annotations for the SNP and mRNA
transcript are cis or trans where cis is 61 Mb (Dist_to_Trait and
cis_trans); the asymptotic p-value, empirical p-value, regression r-
squared and regression beta for the correlation (pvalue, empP, r2
and beta) note the empirical p-values equal to 0.000999 in the
table represent p-values less than 0.001 (based on 1K permuta-
tions); and the number of AA, AB and BB genotypes used in the
correlation (Num_AA, Num_AB and Num_BB).
Found at: doi:10.1371/journal.pgen.1000952.s013 (7.79 MB
XLS)
Text S1 Genetic control of DNA methylation and expression
across human brain tissues.
Found at: doi:10.1371/journal.pgen.1000952.s014 (0.06 MB
DOC)
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